Key Takeaways

• The global IV therapy market currently generates $45.7 billion in revenue, according to data published by BCC Research.
• This industry is forecast to expand at a 6% CAGR over the next three to five years, with annual growth estimates ranging from 4.1% to 7.2% for the period between 2021 and 2026.
• Within this industry, the global in-home IV therapy market size is currently valued at between $18.3 billion and $21 billion, while the global nutrient IV therapy market currently generates $13.8 billion in revenue, with parental nutrition sales of $6 billion annually and enteral sales of $7.8 billion per year.

Introduction

I. Global IV Therapy Market Size & Growth

i) Market Size

• The global IV therapy market currently generates $45.7 billion in revenue, according to data published by BCC Research.

• BCC Research reported in 2019 that the infusion therapy industry would grow from $40.7 billion in revenue as of 2018 to $54.5 billion by 2023, based on a CAGR forecast of 6% during the period.
• Leveraging this revenue data and CAGR estimate, the current market size for IV therapy worldwide can be estimated at $45.7 billion as of 2020. The details of this calculation have been provided within the Research Strategy section at the end of this research brief for review, as desired.
• Notably, BCC Research currently represents the sole, reputable estimate for the global IV therapy industry that is available in the public domain.
• Although an exhaustive search process was conducted to corroborate this market size, all available data was either behind paywalls (e.g., Transparency Market Research, Data Intelligence, ResearchAndMarkets) or deemed to be lacking in credibility (e.g., Reports And Data published a global IV therapy market size of $10.8 billion as of 2027 based on a CAGR of 4.1% between 2017 and 2027. Notably, this market estimate is well below the current size of key industry segments, such as in-home infusions, and is therefore invalid).
• Meanwhile, data on the volume of infusions globally was not readily available.

ii) Growth Forecast

• This global IV therapy market is forecast to expand at a 6% CAGR over the next three to five years, with annual growth estimates ranging from 4.1% to 7.2% between 2021 and 2026.
•  BCC Research currently represents the most moderate estimate for market growth through 2023, with a projected CAGR of 6%.
• More conservative market researchers (e.g., ResearchAndMarkets) project that the global IV therapy market will continue to expand at a CAGR as low as 4.1% through 2026, while aggressive estimates (e.g., Data Mine Intelligence) project growth rates as high as 7.2% over the period. 

 

Source

 

II. Global IV Therapy Market Segmentation

i) In-Home/Out-of-Home IV Therapy

• The global in-home IV therapy market size is currently valued at between $18.3 billion and $21 billion as of 2020, or over 40% of the global infusion therapy industry, according to top-tier market researchers such as Grand View Research and Mordor Intelligence.
• Notably, estimates for this segment of the global infusion industry reach as high as $27.3 billion as of 2019, per Fortune Business Insights.
• In tandem, the market size for out-of-home infusions can be estimated at between $24.7 billion and $27.4 billion, by leveraging data on the in-home segment of this industry from Grand View Research and Mordor Intelligence alongside the BCC Research estimate for the total size of the global IV therapy market ($45.7 billion as of 2020). The details of the underlying calculations for these figures have been provided within the Research Strategy section at the end of this research brief for review, as desired.
• Meanwhile, the growth trajectory of these two market segments appears to be consistent with the industry at large (6%), with Grand View Research and Mordor Intelligence forecasting that in-home infusions will expand slightly faster than out-of-home through 2026 with a CAGR of between 6.5% and 8.5% for the next five or more years.

ii) Nutrient IV Therapy

• Finally, the global nutrient IV therapy market currently generates $13.8 billion in revenue, or approximately 30% of global IV therapy sales, with parental nutrition sales of $6 billion annually and enteral sales of $7.8 billion per year.
• Specifically for parental nutrition, the market was valued at $6 billion in 2020 according to Grand View Research, with a projected CAGR of 5.9%.
• This estimate is corroborated by Global Market Insights, which reports a market value of $5.3 billion in 2020 for this sub-segment.
• Separately, the global enteral nutrition industry reached $6.8 billion in 2018 or $7.8 billion in 2020, growing at a CAGR of 7.1% during the period, according to researchers including Allied Market Research and ResearchAndMarkets.
• The details associated with calculations for the 2020 enteral nutrition market size and global nutrient IV therapy market size have been provided within the Research Strategy section at the end of this research brief for review, as desired.

Research Strategy

 

Source

 

• Conservative estimate for the market size for global out-of-home infusions: Total size of the global IV therapy market of $45.7 billion — Mordor Intelligence estimate for global at-home infusions of $21 billion = $24.7 billion.
• Aggressive estimate for the market size for global out-of-home infusions: Total size of the global IV therapy market of $45.7 billion — Grand View Research estimate for global at-home infusions of $18.3 billion= $27.4 billion.

• In order to estimate the current size of the enteral nutrition industry, the research team combined data from Allied Market Research with the OMNI CAGR calculator, as depicted below.

 

Source

 

• Additionally, the total size of the global nutrient infusion market was calculated as follows: Grand View Research estimate of parenteral infusion market of $6 billion + Allied Market Research estimate of enteral infusion market of $7.8 billion = $13.8 billion.